SCHEMBL15314324

SCHEMBL15314324

O=NCCc1ccc(Br)cc1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 3/20 0.50
▸ HTR2A P28223 1/20 0.50
▸ POLB P06746 1/20 0.39
▸ CTDSP1 Q9GZU7 1/20 0.39
▸ CA1 P00915 2/20 0.39
▸ CA2 P00918 2/20 0.39
▸ CA4 P22748 2/20 0.39
▸ CA9 Q16790 2/20 0.39
▸ CYP2A6 P11509 1/20 0.38
▸ IDO1 P14902 2/20 0.38
▸ FFAR1 O14842 1/20 0.37
▸ FFAR4 Q5NUL3 1/20 0.37
▸ COPS5 Q92905 1/20 0.37
▸ CA12 O43570 1/20 0.36
▸ GPR52 Q9Y2T5 1/20 0.36
▸ PDPK1 O15530 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13824929 0.86 TAAR1 (0.46) TAAR1HTR2APOLBCTDSP1IDO1
SCHEMBL24667496 0.76 GFER (0.59) CA1CA2CA9CA12
SCHEMBL15813137 0.76 ESR1 (0.59) TAAR1CA1CA2
SCHEMBL12222200 0.76 CYP1A2 (0.50) TAAR1CA1CA2CA9CYP2A6
SCHEMBL626076 0.76 TAAR1 (0.68) TAAR1HTR2APOLBCTDSP1CYP2A6
SCHEMBL1844610 0.76 TAAR1 (0.45) TAAR1HTR2APOLBCTDSP1CA1
SCHEMBL944031 0.75 HIF1A (0.52) TAAR1HTR2ACYP2A6FFAR1
SCHEMBL22610186 0.73 TAAR1 (0.42) TAAR1HTR2APOLBCTDSP1CA1
SCHEMBL1046235 0.72 TAAR1 (0.56) TAAR1HTR2APOLBCTDSP1CA1
SCHEMBL13063103 0.71 TAAR1 (0.55) TAAR1CA1CA2CA9IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO disclosed
US-8557726-B2 Chiral heterogeneous catalyst for assymmetric nitroaldol reaction COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2013-10-15 — — US disclosed
Send feedback